EODData

FRA, 8LY: ONCOZENGE AB

30 Oct 2026
LAST:

0.2585

CHANGE:
 0.01
OPEN:
0.2585
HIGH:
0.2585
ASK:
0.0000
VOLUME:
0
CHG(%):
3.54
PREV:
0.2680
LOW:
0.2585
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Oct 260.25850.25850.25850.25850
29 Oct 260.26800.26800.26800.26800
28 Oct 260.27000.27000.27000.27000
27 Oct 260.27400.27400.27400.27400
23 Oct 260.28100.28100.28100.28100
22 Oct 260.28600.28600.28600.28600
21 Oct 260.27950.27950.27950.27950
20 Oct 260.27700.27700.27700.27700
19 Oct 260.29550.29550.29550.29550
16 Oct 260.27600.27600.27600.27600

PROFILE

Name:ONCOZENGE AB
About:OncoZenge AB (publ), a pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of pain in the oral cavity. The company was incorporated in 2020 and is headquartered in Bromma, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:GustavslundsvAegen 34, Bromma, Sweden, 167 51
Website:https://oncozenge.com
ISIN:SE0015504097

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.20 
PEG Ratio:0.00 
Price to Sales:2.43 
Price to Book:0.35 
Operating Margin:-5.92 
Return on Assets:-0.76 
Return on Equity:-2.31 
Revenue:2.66M 
EBITDA:7.27M 
Shares:11.71M 
Market Cap:3.03M 

TECHNICAL INDICATORS

MA5:0.274.6%
MA10:0.287.0%
MA20:0.2911.8%
MA50:0.3327.6%
MA100:0.4781.6%
MA200:0.5094.6%
RSI14:44.47
WPR14:-100.00 
MTM14:-0.05
ROC14:-0.16 
ATR:0.02 
Week High:0.288.7%
Week Low:0.260.0%
Month High:0.3638.5%
Month Low:0.2694.6%
Year High:0.75191.7%
Year Low:0.260.0%
Volatility:68.40